Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/33108
DC FieldValueLanguage
dc.contributor.authorDamevska, Katerinaen_US
dc.contributor.authorSimeonovski, Viktoren_US
dc.date.accessioned2025-03-24T11:29:22Z-
dc.date.available2025-03-24T11:29:22Z-
dc.date.issued2022-05-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/33108-
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofDermatologic Therapyen_US
dc.titleCovid-19 vaccine associated erythema nodosum: Factors to consideren_US
dc.typeArticleen_US
dc.identifier.doi10.1111/dth.15410-
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15410-
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/dth.15410-
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15410-
dc.identifier.volume35-
dc.identifier.issue5-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

19
checked on May 3, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.